Patents Examined by Angela M Bertagna
  • Patent number: 10266893
    Abstract: Disclosed herein is a system and method for increasing the fidelity of measured genetic data, for making allele calls, and for determining the state of aneuploidy, in one or a small set of cells, or from fragmentary DNA, where a limited quantity of genetic data is available. Poorly or incorrectly measured base pairs, missing alleles and missing regions are reconstructed using expected similarities between the target genome and the genome of genetically related individuals. In accordance with one embodiment, incomplete genetic data from an embryonic cell are reconstructed at a plurality of loci using the more complete genetic data from a larger sample of diploid cells from one or both parents, with or without haploid genetic data from one or both parents. In another embodiment, the chromosome copy number can be determined from the measured genetic data, with or without genetic information from one or both parents.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: April 23, 2019
    Assignee: Natera, Inc.
    Inventors: Matthew Rabinowitz, Milena Banjevic, Zachary Demko, David Johnson, Dusan Kijacic, Dimitri Petrov, Joshua Sweetkind-Singer, Jing Xu
  • Patent number: 10260096
    Abstract: Disclosed herein is a system and method for increasing the fidelity of measured genetic data, for making allele calls, and for determining the state of aneuploidy, in one or a small set of cells, or from fragmentary DNA, where a limited quantity of genetic data is available. Poorly or incorrectly measured base pairs, missing alleles and missing regions are reconstructed using expected similarities between the target genome and the genome of genetically related individuals. In accordance with one embodiment, incomplete genetic data from an embryonic cell are reconstructed at a plurality of loci using the more complete genetic data from a larger sample of diploid cells from one or both parents, with or without haploid genetic data from one or both parents. In another embodiment, the chromosome copy number can be determined from the measured genetic data, with or without genetic information from one or both parents.
    Type: Grant
    Filed: March 1, 2017
    Date of Patent: April 16, 2019
    Assignee: Natera, Inc.
    Inventors: Matthew Rabinowitz, Milena Banjevic, Zachary Demko, David Johnson, Dusan Kijacic, Dimitri Petrov, Joshua Sweetkind-Singer, Jing Xu
  • Patent number: 10253376
    Abstract: LAMP primer sets for detecting eight mastitis pathogens are disclosed. Methods and kits of using the primer sets to simultaneously detect at least two of the eight mastitis pathogens are also described.
    Type: Grant
    Filed: October 13, 2014
    Date of Patent: April 9, 2019
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Doerte Doepfer, Kelly Anklam
  • Patent number: 10233444
    Abstract: The invention relates to methods for the detection of a specific sequence of RNA in a cell or tissue sample. The invention also relates to methods to enzymatically manipulate the RNA in a crude cell lysate in a number of applications.
    Type: Grant
    Filed: June 6, 2018
    Date of Patent: March 19, 2019
    Assignee: APPLIED BIOSYSTEMS, LLC
    Inventors: Brittan Pasloske, Quoc Hoang
  • Patent number: 10190177
    Abstract: The invention provides a rapid, accurate, sensitive, and low-cost detection method for screening a biological sample for one or more desired bacterial species. The inventive method employs a two-step multiplex real-time PCR assay that comprises an internal amplification control and specific primer sets to detect and discriminate bacterial species based the unique melting temperatures of specific DNA sequences of each strain.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: January 29, 2019
    Assignee: The Curators of the University of Missouri
    Inventors: Azlin Mustapha, Prashant Singh
  • Patent number: 10190178
    Abstract: Methods for the rapid detection of the presence or absence of mecC-containing Staphylococcus aureus (mecC-MRSA) in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers, probes targeting the genes for mecC-MRSA, along with kits are provided that are designed for the detection of mecC-MRSA.
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: January 29, 2019
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Jenny A. Johnson, Ashley Hayes
  • Patent number: 10184122
    Abstract: The present invention provides methods, compositions and kits for using a transposase and a transposon end for generating extensive fragmentation and 5?-tagging of double-stranded target DNA in vitro, then using a DNA polymerase for generating 5?- and 3?-tagged single-stranded DNA fragments without performing a PCR amplification reaction, wherein the first tag on the 5?-ends exhibits the sequence of the transferred transposon end and optionally, an additional arbitrary sequence, and the second tag on the 3?-ends exhibits a different sequence from the sequence exhibited by the first tag. The method is useful for generating 5?- and 3?-tagged DNA fragments for use in a variety of processes, including processes for metagenomic analysis of DNA in environmental samples, copy number variation (CNV) analysis of DNA, and comparative genomic sequencing (CGS), including massively parallel DNA sequencing (so-called “next generation sequencing).
    Type: Grant
    Filed: July 21, 2015
    Date of Patent: January 22, 2019
    Assignee: Epicentre Technologies Corporation
    Inventors: Haiying Li Grunenwald, Nicholas Caruccio, Jerome Jendrisak, Gary Dahl
  • Patent number: 10174383
    Abstract: A method of estimating the amount of a methylated locus is provided. In certain embodiments the method comprises: digesting a nucleic acid sample that contains both unmethylated and methylated copies of a genomic locus with an MspJI family member to produce a population of fragments that are in the range of 20-40 nucleotides in length, ligating adaptor sequence A and adaptor sequence B to the respective ends of a target fragment of sequence X, and quantifying the amount of ligation products of formula A-X-B. A kit for performing the method is also provided.
    Type: Grant
    Filed: July 30, 2015
    Date of Patent: January 8, 2019
    Assignee: Vanadis Diagnostics
    Inventors: Carl Oscar Fredrik Dahl, Olof John Ericsson, Johan Banér
  • Patent number: 10167501
    Abstract: The present invention relates to methods and apparatuses for amplifying, detecting, and optionally quantifying, nucleic acids. In one aspect the method comprises (a) providing a reaction volume comprising (i) a first electrode comprising an electrochemically-active conducting polymer, a first single-stranded nucleic acid molecule capable of hybridizing to a target nucleic acid, wherein the first nucleic acid molecule is covalently attached to the electrochemically-active conducting polymer, and (ii) a second electrode, (b) providing a reaction mixture to the reaction volume, the reaction mixture comprising a target nucleic acid, a nucleic acid polymerase, a redox couple, and nucleic acid amplification reagents, (c) amplifying the nucleic acid, and (d) measuring the impedance of the first electrode at least once during the nucleic acid amplification reaction.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: January 1, 2019
    Assignee: AUCKLAND UNISERVICES LIMITED
    Inventors: Nihan Aydemir, Jadranka Travas-Sejdic, Clive William Evans, David Edward Williams
  • Patent number: 10160995
    Abstract: Methods and compositions for enriching a population of particles containing an analyte are disclosed. In one embodiment, enrichment beads are used that are larger in size than the beads used for amplification. A separation device is employed that can retain larger beads with bound amplified beads. The technique finds many uses, including enriching for beads with clonally amplified template, which can be used in a variety of assays, including nucleic acid sequencing.
    Type: Grant
    Filed: April 29, 2014
    Date of Patent: December 25, 2018
    Assignee: QIAGEN WALTHAM, INC.
    Inventors: Jerzy Olejnik, Steven Gordon, Martina Werner
  • Patent number: 10138513
    Abstract: Provided is a gene amplifying and detecting device. The gene amplifying and detecting device includes: a gene amplifying chip including a chamber formed therein; a reaction solution filled in the chamber and including a fluorescent material; a light source located at one side of the gene amplifying chip; a light detector located at the other side of the gene amplifying chip; and a graphene heater formed on an inner surface or outer surface of the gene amplifying chip so as to heat the reaction solution.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: November 27, 2018
    Assignee: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE
    Inventors: Kwang Hyo Chung, Jin Tae Kim, Yo Han Choi, Choon Gi Choi, Hong Kyw Choi, Young Jun Yu, Doo Hyeb Youn, Jin Sik Choi
  • Patent number: 10131935
    Abstract: Parallel isolation of a double-stranded nucleic acid and a single-stranded nucleic acid is possible from a sample that contains these acids, without separating the acids, by mixing the sample with a lysis buffer having high salt concentration or low salt concentration, or having a proteolytic enzyme. The sample that contains nucleic acid before its lysis, or the sample that has already been lysed or homogenized, is adjusted with a binding buffer in such a manner that the total nucleic acid is adsorbed onto a solid carrier. The binding buffer contains at least one non-ionic detergent in a high concentration. With the exception of the detergent, the sample contains no other non-acidic organic component miscible in water. The carrier with the adsorbed total nucleic acid is removed. The adsorbed total nucleic acid is washed and eluted.
    Type: Grant
    Filed: January 12, 2009
    Date of Patent: November 20, 2018
    Assignee: AJ INNUSCREEN GmbH
    Inventor: Timo Hillebrand
  • Patent number: 10113206
    Abstract: The present invention relates to compositions, methods, and kits for determining the presence or absence of HIV in a sample, in particular for determining HIV-1 group M, HIV-1 group O, and/or HIV-2, in particular for simultaneous determining of HIV-1 group M, HIV-1 group O, and HIV-2.
    Type: Grant
    Filed: March 21, 2014
    Date of Patent: October 30, 2018
    Assignee: Grifols Therapeutics Inc.
    Inventors: Danuta Wronska, Terri W Journigan, James D Mellott
  • Patent number: 10100353
    Abstract: The present invention relates to a method and a kit of parts for detecting the presence or absence of one or more target nucleic acid sequences in a sample, the method comprising a sequence of steps for pre-amplifying the sample by means of a polymerase chain reaction, followed by a sequence of steps comprising an isothermal amplification of the pre-amplified sample, wherein the isothermal amplification comprises a pair of primers comprising a forward primer having a 3? part that is substantially complementary to a first part of the target sequence, the presence or absence of which is to be detected, and a 5? part that is substantially homolog to a second part of the target sequence, and a reverse primer comprising a 3? part that is substantially homolog to a fourth part of the target sequence and a 5? part that is substantially complementary to a third part of the target sequence.
    Type: Grant
    Filed: May 13, 2013
    Date of Patent: October 16, 2018
    Inventor: Peter Warthoe
  • Patent number: 10100347
    Abstract: The invention provides materials and methods to identify and analyze in a genome-wide manner the structural determinants of this organization. Next generation sequencing methods, combined with a novel assay and integrated data analysis, are used to map the long-range interactions in chromatin that are involved in the regulation of transcription.
    Type: Grant
    Filed: April 26, 2016
    Date of Patent: October 16, 2018
    Assignee: Board of Regents, The University of Texas System
    Inventors: Zbyszek Otwinowski, Dominika Borek
  • Patent number: 10083273
    Abstract: Disclosed herein is a system and method for increasing the fidelity of measured genetic data, for making allele calls, and for determining the state of aneuploidy, in one or a small set of cells, or from fragmentary DNA, where a limited quantity of genetic data is available. Poorly or incorrectly measured base pairs, missing alleles and missing regions are reconstructed using expected similarities between the target genome and the genome of genetically related individuals. In accordance with one embodiment, incomplete genetic data from an embryonic cell are reconstructed at a plurality of loci using the more complete genetic data from a larger sample of diploid cells from one or both parents, with or without haploid genetic data from one or both parents. In another embodiment, the chromosome copy number can be determined from the measured genetic data, with or without genetic information from one or both parents.
    Type: Grant
    Filed: July 23, 2013
    Date of Patent: September 25, 2018
    Assignee: Natera, Inc.
    Inventors: Matthew Rabinowitz, Milena Banjevic, Zachary Demko, David Johnson, Dusan Kijacic, Dimitri Petrov, Joshua Sweetkind-Singer, Jing Xu
  • Patent number: 10081839
    Abstract: Disclosed herein is a system and method for increasing the fidelity of measured genetic data, for making allele calls, and for determining the state of aneuploidy, in one or a small set of cells, or from fragmentary DNA, where a limited quantity of genetic data is available. Poorly or incorrectly measured base pairs, missing alleles and missing regions are reconstructed using expected similarities between the target genome and the genome of genetically related individuals. In accordance with one embodiment, incomplete genetic data from an embryonic cell are reconstructed at a plurality of loci using the more complete genetic data from a larger sample of diploid cells from one or both parents, with or without haploid genetic data from one or both parents. In another embodiment, the chromosome copy number can be determined from the measured genetic data, with or without genetic information from one or both parents.
    Type: Grant
    Filed: January 23, 2017
    Date of Patent: September 25, 2018
    Assignee: Natera, Inc
    Inventors: Matthew Rabinowitz, Milena Banjevic, Zachary Demko, David Johnson, Dusan Kijacic, Dimitri Petrov, Joshua Sweetkind-Singer, Jing Xu
  • Patent number: 10053727
    Abstract: The invention provides an oligonucleotide comprising a nucleotide sequence consisting of SEQ ID NO: 1. The invention also provides method for detecting target DNA in a sample with the oligonucleotide.
    Type: Grant
    Filed: June 13, 2015
    Date of Patent: August 21, 2018
    Assignee: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Shou-Mei Wu, Chung-An Chen
  • Patent number: 10041106
    Abstract: Disclosed are methods and compositions for amplification of genetic material, including isothermal WGA of single cells.
    Type: Grant
    Filed: May 4, 2012
    Date of Patent: August 7, 2018
    Assignee: Progenity, Inc.
    Inventors: Haichuan Zhang, Zuxu Yao, Kerry Gunning
  • Patent number: 10036012
    Abstract: The present invention provides methods, compositions and kits for targeted nucleic acid sequence enrichment in a nucleic acid sample and for high efficiency nucleic acid library generation for next generation sequencing (NGS). Specifically, the methods, compositions and kits provided herein are useful for the production and capture of amplification-ready, target-specific and strand-specific regions of interest from nucleic acid samples containing complex DNA.
    Type: Grant
    Filed: March 28, 2017
    Date of Patent: July 31, 2018
    Assignee: NUGEN TECHNOLOGIES, INC.
    Inventors: Doug Amorese, Chris Armour, Nurith Kurn